Reversible posterior leukoencephalopathy syndrome in systemic lupus erythematosus with thrombocytopenia treated with cyclosporine

被引:54
作者
Shin, KC [1 ]
Choi, HJ [1 ]
Bae, YD [1 ]
Lee, JC [1 ]
Lee, EB [1 ]
Song, YW [1 ]
机构
[1] Seoul Natl Univ, Coll Med, Med Res Ctr, Dept Internal Med, Seoul, South Korea
关键词
systemic lupus erythematosus; cyclosporine; reversible posterior leukoencephalopathy syndrome;
D O I
10.1097/01.rhu.0000164825.63063.43
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Thrombocytopenia is one of the common manifestations of systemic lupus erythematosus (SLE). Its treatment consists of corticosteroids and/or other immunosuppressive drug such as azathioprine, vincristine, cyclosporine, and mycophenolate mofetil. Common adverse reactions of immunosuppressive treatment are infections, hematologic and liver function abnormalities, but neurologic complications may also be seen. Reversible posterior leukoencephalopathy syndrome (RPLS) is a syndrome manifested by headache, nausea, vomiting, seizures, cortical blindness, and visual disturbances. Neuroimaging shows bilateral subcortical and cortical edema with prominent posterior distribution. Moreover, treatment with immunosuppressive drugs such as cyclosporine, cisplatin, tacrolimus, and interferon-alpha can induce a condition resembling RPLS. We report a case of a young woman with SLE and thrombocytopenia, who developed severe perspiration, headache, and seizure after receiving cyclosporine. A brain magnetic resonance image showed multiple high signal intensities on T2-weighted images predominantly located at the parietooccipital lobe. The patient recovered completely clinically and radiologically after discontinuing cyclosporine.
引用
收藏
页码:164 / 166
页数:3
相关论文
共 11 条
[1]   CYCLOSPORINE-ASSOCIATED CENTRAL NERVOUS-SYSTEM TOXICITY AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION [J].
ATKINSON, K ;
BIGGS, J ;
DARVENIZA, P ;
BOLAND, J ;
CONCANNON, A ;
DODDS, A .
TRANSPLANTATION, 1984, 38 (01) :34-37
[2]   Posterior leukoencephalopathy without severe hypertension - Utility of diffusion-weighted MRI [J].
Ay, H ;
Buonanno, FS ;
Schaefer, PW ;
Le, DA ;
Wang, B ;
Gonzalez, RG ;
Koroshetz, WJ .
NEUROLOGY, 1998, 51 (05) :1369-1376
[3]   CYCLOSPORINE - A REVIEW AND ITS SPECIFIC USE IN LIVER-TRANSPLANTATION [J].
DEGROEN, PC .
MAYO CLINIC PROCEEDINGS, 1989, 64 (06) :680-689
[4]  
DURRANT S, 1982, LANCET, V2, P829
[5]   Posterior leukoencephalopathy syndrome [J].
Garg, RK .
POSTGRADUATE MEDICAL JOURNAL, 2001, 77 (903) :24-28
[6]   A reversible posterior leukoencephalopathy syndrome [J].
Hinchey, J ;
Chaves, C ;
Appignani, B ;
Breen, J ;
Pao, L ;
Wang, A ;
Pessin, MS ;
Lamy, C ;
Mas, JL ;
Caplan, LR .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (08) :494-500
[7]  
KUNZENDORF U, 1988, LANCET, V1, P1223
[8]  
Schwartz RB, 1996, NEW ENGL J MED, V334, P1743
[9]   CYCLOSPORINE NEUROTOXICITY AND ITS RELATIONSHIP TO HYPERTENSIVE ENCEPHALOPATHY - CT AND MR FINDINGS IN 16 CASES [J].
SCHWARTZ, RB ;
BRAVO, SM ;
KLUFAS, RA ;
HSU, LG ;
BARNES, PD ;
ROBSON, CD ;
ANTIN, JH .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1995, 165 (03) :627-631
[10]  
THOMPSON CB, 1984, LANCET, V2, P1116